| CAS: | 89464-63-1 | |||
| 分子式: | C6H9NO5 | |||
| 分子量: | 175.14 | |||
| 熔点: | 46-48 °C | |||
| 中文名称: |
| |||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||||
| D854500 | MACKLIN | 二甲基乙二酰氨基乙酸 | >98% | 319元/100mg; 526元/250mg; 1146元/1g; 3786元/5g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20℃ 状态:白色到灰白色固体 DMOG 是一种有效的 HI F脯氨酰羟化酶抑制剂,以及 α-ketoglutarate 辅因子的拮抗剂 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| D793349 | MACKLIN | 二甲基乙二酰氨基乙酸 | 10mM in DMSO | 715元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| D5480 | TCI | Dimethyloxaloylglycine | >97.0%(GC) | 160元/50MG; 640元/250MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| D3695 | Sigma-Aldrich | DMOG | ≥98% (HPLC) | 1176.21元/10 MG; 4747.63元/50 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 应用 二甲基草酰甘氨酸(DMOG)用作TET3蛋白抑制剂。
包装 10, 50 mg in glass bottle 生化/生理作用 DMGO是一种细胞渗透脯氨酸-4-羟化酶抑制剂,上调HIF(缺氧诱导因子)。HIF蛋白质水平-1α 后转录亚基被脯氨酰和天冬酰胺羟化酶调节(PAH)。PAH活性抑制增强了内源性HIF-1α水平。DMGO是一种细胞透过性、含蛋白脯氨酰羟化酶结构域的竞争性抑制剂(PHDs和HIF-PHs)。已经发现DMOG通过葡萄糖代谢保存对于NFG缺乏细胞培养有神经元保护效果。DMOG在兔子缺血再灌注模型中也可以减轻心肌损伤。DMOG比以前的抑制剂4-苯基-吡啶-2,5-二羧酸更有效(R395889;sigma-aldrich稀有化学文库)。IC50 is 5.18 μM. 特点和优势 该化合物是基因调控研究的特色产品。点击此处以了解更多的基因调控特色产品。可访问sigma.com/discover-bsm了解更多关于用于其他研究领域生物活性小分子。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 400091 | Sigma-Aldrich | HIF-Hydroxylase Inhibitor, DMOG-CAS 89464-63-1-Calbiochem | The HIF-Hydroxylase Inhibitor, DMOG, also referenced under CAS 89464-63-1, controls the biological activity of HIF-Hydroxylase. This small molecule/inhibitor is primarily used for Cell Structure appli | 1364.79元/50 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 A cell-permeable 2-OG (2-oxoglutarate) analog that is expected to act as a competitive inhibitor against all 2-OG-dependent dioxygenases. Effectively upregulates normoxia HIF-α transcription activity (effective conc. = 1 mM in cultures) by inhibiting HIF-PH- (HIF-α-prolyl hydroxylase) catalyzed ODD (oxygen-dependent degradation domain) Prolyl hydroxylation (Pro564 and Pro530 in HIF-1α and HIF-2α, respectively) and aspartyl/asparanginyl β-hydroxylase-catalyzed CAD Asp hydroxylation (Asn803 and Asn851 in HIF-1α and HIF-2α, respectively), resulting in a blockage of pVHL (von Hippel-Lindau) ubiquitin ligase complex-mediated HIF-α degradation and a simultaneous promotion of HIF CAD (COOH-terminal activation domain) p300/CBP association. DMOG is also demonstrated to augment artery ligation-induced up-regulation of HIF-1α and FLK (by 100% and 40%, respectively, in 11 days; 8 mg/0.5 ml/animal/i.p.; q.o.d.) in muscle tissues in a murine ischaemic model in vivo. 包装 50 mg in Glass bottle 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. 其他说明 Pollard, P.J., et al. 2008. Biochem. J.416, 387. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| M04025 | Fluorochem | Dimethyloxallyl glycine | 95% | 3718元/250mg; 11770元/1g; 42284元/5g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||